What is CAR-T Cell Therapy?
CAR-T cell therapy collects a patient's T cells, genetically engineers them to recognise a cancer target, expands them, then returns them after lymphodepleting treatment. The pathway includes apheresis, off-site or on-site manufacturing, possible bridging therapy, lymphodepletion, a single cell infusion and close post-infusion monitoring.





